Your browser is no longer supported. Please, upgrade your browser.
Settings
ICAD iCAD, Inc. daily Stock Chart
ICAD [NASD]
iCAD, Inc.
Index- P/E- EPS (ttm)-0.54 Insider Own2.70% Shs Outstand17.26M Perf Week-10.22%
Market Cap78.88M Forward P/E91.40 EPS next Y0.05 Insider Trans0.00% Shs Float14.46M Perf Month8.81%
Income-9.00M PEG- EPS next Q-0.13 Inst Own22.70% Short Float3.01% Perf Quarter0.44%
Sales25.60M P/S3.08 EPS this Y-282.30% Inst Trans- Short Ratio2.69 Perf Half Y38.91%
Book/sh0.41 P/B11.15 EPS next Y145.50% ROA-31.00% Target Price7.00 Perf Year34.81%
Cash/sh0.71 P/C6.47 EPS next 5Y15.00% ROE-92.80% 52W Range2.42 - 6.10 Perf YTD23.51%
Dividend- P/FCF- EPS past 5Y5.10% ROI-40.90% 52W High-25.08% Beta1.33
Dividend %- Quick Ratio1.50 Sales past 5Y-5.00% Gross Margin75.80% 52W Low88.45% ATR0.41
Employees95 Current Ratio1.60 Sales Q/Q-11.40% Oper. Margin-31.40% RSI (14)40.02 Volatility8.02% 8.66%
OptionableYes Debt/Eq1.90 EPS Q/Q-122.10% Profit Margin-35.20% Rel Volume0.17 Prev Close4.58
ShortableYes LT Debt/Eq1.62 EarningsMar 18 AMC Payout- Avg Volume161.69K Price4.57
Recom- SMA20-8.06% SMA50-7.85% SMA20020.64% Volume27,806 Change-0.22%
Dec-09-08Reiterated Canaccord Adams Buy $5 → $3.50
Aug-01-08Reiterated MDB Capital Group Buy $5.50 → $6
May-14-08Reiterated Canaccord Adams Buy $4 → $4.50
Feb-14-08Initiated Sun Trust Rbsn Humphrey Buy $4
Jan-24-07Reiterated Dawson James Speculative Buy $4 → $5
Apr-15-19 08:00AM  iCAD Wins Three-System Public Bid with Leading Cancer Organization in Spain, Expanding European Access to Innovative Cancer Treatments with the Xoft System GlobeNewswire
Apr-04-19 10:53AM  iCAD to Highlight ProFound AI Solution for Digital Breast Tomosynthesis at 2019 Society of Breast Imaging Annual Symposium GlobeNewswire +11.89%
Mar-29-19 06:48PM  icad Inc (ICAD) Files 10-K for the Fiscal Year Ended on December 31, 2018 GuruFocus.com +6.82%
Mar-28-19 08:22AM  iCAD Appoints Stacey Stevens as President GlobeNewswire +5.91%
Mar-26-19 08:00AM  iCAD to Present Corporate Overview at the Jefferies 2019 Radiation Oncology & Energy-Based Therapeutics Summit GlobeNewswire
Mar-25-19 10:10AM  ICAD: ProFound AI Makes U.S. Debut, Roll-Out Accelerating. More AI Products Could Soon Follow Zacks Small Cap Research +6.05%
Mar-21-19 04:43AM  Edited Transcript of ICAD earnings conference call or presentation 18-Mar-19 8:30pm GMT Thomson Reuters StreetEvents
Mar-18-19 04:18PM  Icad: 4Q Earnings Snapshot Associated Press
04:01PM  iCAD Reports Fourth Quarter and Full-Year 2018 Financial Results GlobeNewswire
02:30PM  iCAD, Inc. to Host Earnings Call ACCESSWIRE
Mar-14-19 05:29PM  iCAD Reports Strong Momentum of ProFound AI, its Artificial Intelligence-Based Solution for Digital Breast Tomosynthesis Business Wire
08:00AM  iCAD to Present Corporate Overview at the 31st Annual ROTH Conference GlobeNewswire
Mar-13-19 04:30PM  iCAD to Report Fourth Quarter and Fiscal Year Ended December 31, 2018 Financial Results on Monday, March 18 GlobeNewswire
Feb-27-19 04:30PM  iCAD to Partner with Leading Breast Cancer Researchers from Karolinska Institutet to Develop Artificial Intelligence-Based Breast Cancer Risk Prediction Solution GlobeNewswire
Feb-21-19 11:12AM  iCAD to Showcase ProFound AI Solution for Digital Breast Tomosynthesis at ECR 2019 GlobeNewswire
Jan-07-19 08:00AM  Long-Term Study of 1,000 Tumors Demonstrates Effectiveness of iCAD's Xoft Electronic Brachytherapy System for Early-Stage Breast Cancer Treatment GlobeNewswire +9.60%
Jan-03-19 07:00AM  Arcturus Therapeutics Appoints Andrew Sassine as Chief Financial Officer GlobeNewswire
Dec-27-18 04:01PM  iCAD Announces CFO Transition GlobeNewswire
Dec-20-18 07:00AM  iCAD, Inc. Announces $7.0 Million Private Placement of Unsecured Subordinated Convertible Debentures GlobeNewswire
Dec-13-18 06:28PM  Edited Transcript of ICAD earnings conference call or presentation 13-Nov-18 9:30pm GMT Thomson Reuters StreetEvents
Dec-07-18 08:00AM  iCAD Announces FDA Clearance of ProFound AI for Digital Breast Tomosynthesis GlobeNewswire -5.84%
Nov-27-18 01:50PM  ICAD: Confident of FDA Approval of Tomo 2.0 (i.e. ProFound AI). New/Interim CEO Looks Like Perfect Fit Zacks Small Cap Research
Nov-26-18 12:21PM  iCAD Unveils ProFound AI for Digital Breast Tomosynthesis at RSNA 2018 GlobeNewswire
Nov-15-18 09:30AM  How Financially Strong Is iCAD Inc (NASDAQ:ICAD)? Simply Wall St.
Nov-13-18 04:18PM  Icad: 3Q Earnings Snapshot Associated Press +10.63%
04:01PM  iCAD Reports Third Quarter 2018 Financial Results GlobeNewswire
Nov-09-18 08:53AM  iCAD Announces Retirement of CEO, Ken Ferry GlobeNewswire
Nov-06-18 04:05PM  iCAD to Report Third Quarter and Nine Months Ended September 30, 2018 Financial Results on Tuesday, November 13th GlobeNewswire
Oct-30-18 08:00AM  Navicent Health Adopts iCADs Breast Cancer Detection and Therapy Solutions to Enhance Patient Care GlobeNewswire
Oct-23-18 02:01PM  iCAD Announces New Clinical Data on the Xoft Electronic Brachytherapy System for Early-Stage Breast Cancer Treatment Demonstrating Positive Results GlobeNewswire
Oct-11-18 08:00AM  iCAD Announces Exceptional Study Results Demonstrating Significant Advantages of Revolutionary Artificial Intelligence Technology for Digital Breast Tomosynthesis GlobeNewswire +8.31%
Oct-09-18 08:00AM  SUNY Upstate Medical University Selects iCADs Xoft Electronic Brachytherapy System for Early-Stage Breast Cancer Treatment GlobeNewswire
Oct-03-18 08:00AM  Sanford Health Announces Adoption of iCAD's Xoft Electronic Brachytherapy System for Early-Stage Breast Cancer Treatment GlobeNewswire
Oct-01-18 02:35PM  Independent, Long-Term Study Highlights Effectiveness of iCAD's Xoft Electronic Brachytherapy System for Early-Stage Breast Cancer Treatment GlobeNewswire
Sep-20-18 11:24AM  iCAD Inc (NASDAQ:ICAD): Risks You Need To Consider Before Buying Simply Wall St.
Sep-04-18 11:15AM  ICAD: U.S. Tomo 2.0, Organic Therapy Growth and Leaner Ops Mean Profitability is Realistic Zacks Small Cap Research
Aug-31-18 08:07AM  Edited Transcript of ICAD earnings conference call or presentation 14-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-29-18 08:00AM  iCAD Announces AERB Approval of Xoft System in India GlobeNewswire
Aug-28-18 08:00AM  Medical City Plano, a HCA Healthcare Facility, Adopts iCADs Xoft Electronic Brachytherapy System for Treatment of Early-Stage Breast Cancer GlobeNewswire
07:00AM  Arcturus Therapeutics Appoints Andrew Sassine as Interim Chief Financial Officer GlobeNewswire
Aug-14-18 04:13PM  Icad: 2Q Earnings Snapshot Associated Press
04:01PM  iCAD Reports Second Quarter 2018 Financial Results GlobeNewswire
Aug-08-18 09:14AM  ICAD's stock soars after FDA clearance of breast-density AI software product MarketWatch +7.77%
08:00AM  iCAD Receives FDA Clearance of PowerLook Density Assessment for Digital Breast Tomosynthesis GlobeNewswire
Aug-07-18 08:00AM  iCAD to Report Second Quarter and Six Months Ended June 30, 2018 Financial Results on Tuesday, August 14th GlobeNewswire
Jun-26-18 01:57PM  What Does iCAD Incs (NASDAQ:ICAD) Share Price Indicate? Simply Wall St.
Jun-06-18 08:00AM  iCAD Named 2018 MedTech Breakthrough Award Winner GlobeNewswire
May-22-18 09:20AM  ICAD: Q1 2018 Results: Detection Disappointing But Still Looking For 2.0-Related Inflection in 2H Zacks Small Cap Research
May-21-18 10:03PM  Edited Transcript of ICAD earnings conference call or presentation 14-May-18 8:30pm GMT Thomson Reuters StreetEvents
May-14-18 04:39PM  Icad: 1Q Earnings Snapshot Associated Press
04:01PM  iCAD Reports First Quarter 2018 Financial Results GlobeNewswire
12:15PM  iCAD, Inc. to Host Earnings Call ACCESSWIRE
09:55AM  iCAD Inc (NASDAQ:ICAD): Time For A Financial Health Check Simply Wall St.
May-08-18 08:00AM  iCAD to Report First Quarter 2018 Financial Results on Monday, May 14, 2018 GlobeNewswire
Apr-19-18 08:00AM  iCAD Announces Presentation of Positive Clinical Data on Xoft System for Treatment of Early-Stage Breast Cancer and Gynecological Cancers at ESTRO 37 GlobeNewswire
Apr-12-18 07:40AM  Free Post Earnings Research Report: Nutanixs Revenues Surged 44%; Net Loss Narrowed ACCESSWIRE
Apr-03-18 09:45AM  ICAD: Q4 2017 Results: Tomo Seeing Strong Demand. Plug Pulled on Unprofitable Skin Subscription Biz Zacks Small Cap Research
Mar-23-18 07:21PM  Edited Transcript of ICAD earnings conference call or presentation 22-Mar-18 8:30pm GMT Thomson Reuters StreetEvents
07:23AM  3 Stocks to Watch on Friday: At Home Group Inc (HOME), HTG Molecular Diagnostics Inc (HTGM) and iCAD Inc (ICAD) InvestorPlace
Mar-22-18 04:01PM  iCAD Reports Fourth Quarter and Full-Year 2017 Financial Results GlobeNewswire
01:00PM  iCAD, Inc. to Host Earnings Call ACCESSWIRE
Mar-16-18 08:00AM  iCAD to Report Fourth Quarter and Fiscal 2017 Financial Results on Thursday, March 22, 2018 GlobeNewswire
Mar-01-18 02:00AM  iCAD Granted CE Mark Approval in Europe for PowerLook Tomo Detection 2.0 Artificial Intelligence Solution GlobeNewswire +7.00%
Feb-08-18 10:31AM  iCAD Named a Top Artificial Intelligence Medical Imaging Solution Provider by Healthcare Tech Outlook GlobeNewswire +6.34%
Dec-15-17 10:00AM  ICAD: Study Shows IORT Superior To EBRT in Quality of Life, Cost Zacks Small Cap Research
Dec-12-17 08:00AM  Two Centers from The US Oncology Network Adopt iCADs Xoft Electronic Brachytherapy System for Treatment of Early-Stage Non-Melanoma Skin Cancer GlobeNewswire +7.78%
Dec-07-17 08:00AM  iCAD Announces Study Demonstrating Economic and Health Benefits of Intraoperative Radiation Therapy (IORT) for Early-Stage Breast Cancer Treatment GlobeNewswire +10.26%
Nov-27-17 08:00AM  iCADs PowerLook® Tomo Detection Experiences Growing Adoption GlobeNewswire
Nov-21-17 07:49PM  Are iCAD Incs (ICAD) Interest Costs Too High? Simply Wall St. +5.08%
Nov-20-17 10:30PM  Edited Transcript of ICAD earnings conference call or presentation 8-Nov-17 9:30pm GMT Thomson Reuters StreetEvents
Nov-13-17 05:30PM  ICAD: Q3 Detection and Therapy Results Solid. Tomo Growth To Accelerate Zacks Small Cap Research
Nov-09-17 08:00AM  iCAD Announces Positive Clinical Data on Xoft System for Non-Melanoma Skin Cancer Treatment Selected as Best of ASTRO 2017 GlobeNewswire -10.84%
Nov-08-17 04:01PM  iCAD Reports Third Quarter 2017 Financial Results GlobeNewswire
01:30PM  iCAD, Inc. to Host Earnings Call ACCESSWIRE
08:00AM  Imaging for Women Now Offering iCADs PowerLook® Tomo Detection for Digital Breast Tomosynthesis GlobeNewswire
Nov-01-17 08:00AM  iCAD to Report Third Quarter 2017 Financial Results on Wednesday, November 8 GlobeNewswire
Oct-26-17 08:00AM  iCADs PowerLook Tomo Detection for Digital Breast Tomosynthesis Named 2017 Product of the Year by New Hampshire High Technology Council GlobeNewswire
Sep-25-17 08:00AM  iCAD Announces Presentation of New Clinical Data on Xoft System for Treatment of Nonmelanoma Skin Cancer and Early-Stage Breast Cancer at ASTRO 2017 GlobeNewswire
Sep-20-17 08:00AM  iCAD to Present at the Cantor Fitzgerald Global Healthcare Conference GlobeNewswire
Sep-05-17 08:58PM  ETFs with exposure to iCAD, Inc. : September 6, 2017 Capital Cube
Sep-03-17 08:00PM  iCAD Announces Approval of Xoft® Axxent® Balloon Applicators by China Food & Drug Administration for Treatment of Early-Stage Breast Cancer GlobeNewswire
Aug-31-17 12:42PM  iCAD, Inc. :ICAD-US: Earnings Analysis: Q2, 2017 By the Numbers : August 31, 2017 Capital Cube +6.74%
Aug-30-17 08:00AM  iCAD Announces Approval of Xoft® Axxent® Balloon Applicators by China Food & Drug Administration for Treatment of Early-Stage Breast Cancer GlobeNewswire +10.75%
Aug-17-17 06:16PM  Edited Transcript of ICAD earnings conference call or presentation 8-Aug-17 8:30pm GMT Thomson Reuters StreetEvents
10:20AM  ICAD: A Look Behind Q2 Numbers. U.S. Tomo Launch Encouraging Zacks Small Cap Research
Aug-08-17 04:01PM  iCAD Reports Second Quarter 2017 Financial Results and Announces $13 Million Credit Facility With Silicon Valley Bank GlobeNewswire
10:10AM  Investor Network: iCAD, Inc. to Host Earnings Call ACCESSWIRE
Aug-01-17 08:00AM  iCAD to Present at the Canaccord Genuity 37th Annual Growth Conference GlobeNewswire
Jul-31-17 08:00AM  iCAD to Report Second Quarter 2017 Financial Results on Tuesday, August 8 GlobeNewswire
Jul-27-17 08:00AM  Researchers to Present Clinical Data Supporting Use of Xoft System for Endometrial Cancer Treatment at American Association of Physicists in Medicine Annual Meeting & Exhibition GlobeNewswire
Jul-19-17 08:00AM  iCAD announces positive study results comparing use of companys Xoft® Axxent® Electronic Brachytherapy (eBx®) System® to Mohs surgery in treatment of early-stage non-melanoma skin cancer GlobeNewswire
Jun-06-17 08:00AM  Carolina Breast Imaging Specialists Adopts iCADs Advanced Artificial Intelligence Technology for Digital Breast 3D Tomosynthesis GlobeNewswire
May-26-17 01:11PM  ETFs with exposure to iCAD, Inc. : May 26, 2017 Capital Cube
May-25-17 08:48AM  iCAD, Inc. :ICAD-US: Earnings Analysis: Q1, 2017 By the Numbers : May 25, 2017 Capital Cube
May-22-17 08:00AM  iCAD to Participate in Two Upcoming Investor Conferences GlobeNewswire
May-08-17 10:00AM  ICAD: Q1: Strong Detection Offsets Weakness in NMSC Revenue Zacks Small Cap Research
May-05-17 02:25PM  Edited Transcript of ICAD earnings conference call or presentation 2-May-17 8:30pm GMT Thomson Reuters StreetEvents +7.06%
09:00AM  ICAD: U.S. Tomo Launched, Should Be 2017 Catalyst Zacks Small Cap Research
08:02AM  First-Ever European Analysis of Electronic Brachytherapy Using the Xoft System for Endometrial and Cervical Cancer Treatment to be Presented at European Society for Radiotherapy & Oncology Meeting GlobeNewswire
08:00AM  First-Ever European Analysis of Electronic Brachytherapy Using the Xoft System for Endometrial and Cervical Cancer Treatment to be Presented at European Society for Radiotherapy & Oncology Meeting GlobeNewswire
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the early identification and treatment of cancer in the United States and internationally. It operates through two segments, Cancer Detection and Cancer Therapy. The company provides electronic brachytherapy (eBX) products, including Axxent eBx systems for the treatment of early stage breast cancer, endometrial cancer, cervical cancer, and skin cancer, as well as for treating other cancers or conditions where radiation therapy is indicated comprising intraoperative radiation therapy. It also offers digital mammography computer-aided detection (CAD) products, such as advanced image analysis and workflow solutions in breast imaging, which include PowerLook Mammo Detection, which detects and identifies suspicious masses and micro-calcifications; and PowerLook Advanced Mammography Platform, a computer server residing on a customer's network that receives patient studies from the imaging modality, performs CAD and density assessment analysis, and sends the CAD results to picture archiving and communication system and/or review workstations. In addition, the company's digital mammography CAD products comprise magnetic resonance imaging products to detect breast and prostate cancer; breast tomosynthesis systems; and advanced image analysis and workflow solutions in computed tomography (CT) colonography, including VeraLook that supports the detection of colonic polyps in conjunction with CT colonography. It serves hospitals, ambulatory care centers and free standing radiation oncology facilities, and other office-based uses through sales organizations, as well as through various original equipment manufacturer partners, distributors, and resellers. iCAD, Inc. has a strategic partnership agreement with Invivo Corp. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was founded in 1984 and is headquartered in Nashua, New Hampshire.